Concurrent Investment Advisors, LLC United Therapeutics Corp Transaction History
Concurrent Investment Advisors, LLC
- $4.12 Trillion
- Q1 2025
A detailed history of Concurrent Investment Advisors, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 737 shares of UTHR stock, worth $211,430. This represents 0.01% of its overall portfolio holdings.
Number of Shares
737Holding current value
$211,430% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding UTHR
# of Institutions
733Shares Held
43.6MCall Options Held
124KPut Options Held
122K-
Black Rock Inc. New York, NY5.47MShares$1.57 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.46MShares$1.28 Billion0.03% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.68MShares$767 Million13.34% of portfolio
-
State Street Corp Boston, MA2.23MShares$640 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.11MShares$604 Million1.04% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.1B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...